Brief: Inpixon Says Mapping Selected By Leading Pharmaceutical Co To Provide Visualization Required For Tracking Critical Covid-19 Vaccine-Related Assets
18/11/2020 14:32
Nov 18 (Reuters) - Inpixon INPX.O :
* INPIXON - INPIXON MAPPING SELECTED BY LEADING
PHARMACEUTICAL CO
TO PROVIDE VISUALIZATION REQUIRED FOR TRACKING CRITICAL COVID-19
VACCINE-RELATED ASSETS
Source text for Eikon: ID:nPnb5vJkka
Further company coverage: INPX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XTI Aerospace
See all newsBrief: XTI Aerospace Announces Preliminary Q3 Revenue Of $35.30 Million
XTI Aerospace Q2 revenue surges amid enterprise demand
Brief: XTI Aerospace's Unit XTI Drones Holdings Defaults on Origin Group Notes
Brief: XTI Aerospace Anticipates Q2 Revenue Of $32.40 Million, Gross Profit $5.60 Million, Loss From Operations $9.10 Million
Brief: XTI Aerospace Postpones Release Of Q2 2026 Financial Results